Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69


Fibroblast subtypes define a metastatic matrisome in breast cancer.

Brechbuhl HM, Barrett AS, Kopin E, Hagen JC, Han AL, Gillen AE, Finlay-Schultz J, Cittelly DM, Owens P, Horwitz KB, Sartorius CA, Hansen KC, Kabos P.

JCI Insight. 2020 Feb 11. pii: 130751. doi: 10.1172/jci.insight.130751. [Epub ahead of print]


Cytokeratin 5 alters β-catenin dynamics in breast cancer cells.

McGinn O, Ward AV, Fettig LM, Riley D, Ivie J, Paul KV, Kabos P, Finlay-Schultz J, Sartorius CA.

Oncogene. 2020 Jan 27. doi: 10.1038/s41388-020-1164-0. [Epub ahead of print]


ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases.

Kumthekar P, Tang SC, Brenner AJ, Kesari S, Piccioni DE, Anders CK, Carrillo JA, Chalasani P, Kabos P, Puhalla SL, Tkaczuk KHR, Garcia A, Ahluwalia MS, Wefel JS, Lakhani N, Ibrahim NK.

Clin Cancer Res. 2020 Jan 22. pii: clincanres.3258.2019. doi: 10.1158/1078-0432.CCR-19-3258. [Epub ahead of print]


Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4.

Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM.

Clin Cancer Res. 2019 Jul 1;25(13):3946-3953. doi: 10.1158/1078-0432.CCR-18-2851. Epub 2019 Apr 2.


Imaging Carrier Inhomogeneities in Ambipolar Tellurene Field Effect Transistors.

Berweger S, Qiu G, Wang Y, Pollard B, Genter KL, Tyrrell-Ead R, Wallis TM, Wu W, Ye PD, Kabos P.

Nano Lett. 2019 Feb 13;19(2):1289-1294. doi: 10.1021/acs.nanolett.8b04865. Epub 2019 Jan 29.


Disentangling topographic contributions to near-field scanning microwave microscopy images.

Coakley KJ, Berweger S, Wallis TM, Kabos P.

Ultramicroscopy. 2019 Feb;197:53-64. doi: 10.1016/j.ultramic.2018.11.003. Epub 2018 Nov 12.


Recovery and analysis of transcriptome subsets from pooled single-cell RNA-seq libraries.

Riemondy KA, Ransom M, Alderman C, Gillen AE, Fu R, Finlay-Schultz J, Kirkpatrick GD, Di Paola J, Kabos P, Sartorius CA, Hesselberth JR.

Nucleic Acids Res. 2019 Feb 28;47(4):e20. doi: 10.1093/nar/gky1204.


A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.

Diamond JR, Eckhardt SG, Pitts TM, van Bokhoven A, Aisner D, Gustafson DL, Capasso A, Sams S, Kabos P, Zolman K, Colvin T, Elias AD, Storniolo AM, Schneider BP, Gao D, Tentler JJ, Borges VF, Miller KD.

Breast Cancer Res. 2018 Aug 2;20(1):82. doi: 10.1186/s13058-018-1014-y.


FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.

Wellberg EA, Kabos P, Gillen AE, Jacobsen BM, Brechbuhl HM, Johnson SJ, Rudolph MC, Edgerton SM, Thor AD, Anderson SM, Elias A, Zhou XK, Iyengar NM, Morrow M, Falcone DJ, El-Hely O, Dannenberg AJ, Sartorius CA, MacLean PS.

JCI Insight. 2018 Jul 26;3(14). pii: 120594. doi: 10.1172/jci.insight.120594. eCollection 2018 Jul 26.


A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.

Stoen E, Kabos P, Borden KC, Brown RJ, Borges VF, Diamond JR.

Oncology (Williston Park). 2018 Jun;32(6):298-302. No abstract available.


Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.

Contreras-Zárate MJ, Ormond DR, Gillen AE, Hanna C, Day NL, Serkova NJ, Jacobsen BM, Edgerton SM, Thor AD, Borges VF, Lillehei KO, Graner MW, Kabos P, Cittelly DM.

Front Oncol. 2017 Nov 2;7:252. doi: 10.3389/fonc.2017.00252. eCollection 2017.


A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.

Banerji U, Dean EJ, Pérez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose H, Barrett JC, Carr TH, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley R, Pass M, Rowlands V, Rugman P, Schiavon G, Yates J, Schellens JHM.

Clin Cancer Res. 2018 May 1;24(9):2050-2059. doi: 10.1158/1078-0432.CCR-17-2260. Epub 2017 Oct 24.


Alternative Polyadenylation of PRELID1 Regulates Mitochondrial ROS Signaling and Cancer Outcomes.

Gillen AE, Brechbuhl HM, Yamamoto TM, Kline E, Pillai MM, Hesselberth JR, Kabos P.

Mol Cancer Res. 2017 Dec;15(12):1741-1751. doi: 10.1158/1541-7786.MCR-17-0010. Epub 2017 Sep 14.


Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.

Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM.

Clin Breast Cancer. 2018 Jun;18(3):220-228. doi: 10.1016/j.clbc.2017.06.009. Epub 2017 Jun 29.


The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.

Wellberg EA, Checkley LA, Giles ED, Johnson SJ, Oljira R, Wahdan-Alaswad R, Foright RM, Dooley G, Edgerton SM, Jindal S, Johnson GC, Richer JK, Kabos P, Thor AD, Schedin P, MacLean PS, Anderson SM.

Horm Cancer. 2017 Dec;8(5-6):269-285. doi: 10.1007/s12672-017-0302-9. Epub 2017 Jul 24.


Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Finlay-Schultz J, Gillen AE, Brechbuhl HM, Ivie JJ, Matthews SB, Jacobsen BM, Bentley DL, Kabos P, Sartorius CA.

Cancer Res. 2017 Sep 15;77(18):4934-4946. doi: 10.1158/0008-5472.CAN-16-3541. Epub 2017 Jul 20.


Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer.

Ionkina AA, Tentler JJ, Kim J, Capasso A, Pitts TM, Ryall KA, Howison RR, Kabos P, Sartorius CA, Tan AC, Eckhardt SG, Diamond JR.

Front Oncol. 2017 May 15;7:94. doi: 10.3389/fonc.2017.00094. eCollection 2017.


The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P.

J Natl Compr Canc Netw. 2017 Apr;15(4):494-503.


Electronic and Morphological Inhomogeneities in Pristine and Deteriorated Perovskite Photovoltaic Films.

Berweger S, MacDonald GA, Yang M, Coakley KJ, Berry JJ, Zhu K, DelRio FW, Wallis TM, Kabos P.

Nano Lett. 2017 Mar 8;17(3):1796-1801. doi: 10.1021/acs.nanolett.6b05119. Epub 2017 Feb 7.


PALB2-Positive Breast Cancer in a 40-Year-Old Man.

Iyer P, Jasem J, Springer MA, Klein CE, Kabos P.

Oncology (Williston Park). 2017 Jan 15;31(1):50-2, 54. No abstract available.


Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis MT.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x. Review.


Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.

Overholser L, Shagisultanova E, Rabinovitch RA, Kounalakis N, Diamond J, Finlayson CA, Fisher CM, Kabos P, Elias AD, Borges VF, Mayordomo J.

Oncology (Williston Park). 2016 Dec 15;30(12):1063-70. Review.


Middle-Aged Man With Acute Thrombocytopenia Subsequent to Fluorouracil and Oxaliplatin Chemotherapy for Colorectal Cancer.

Schade H, Davis L, Kabos P.

Oncology (Williston Park). 2016 Nov 15;30(11):992-4, 1000-1. No abstract available.


Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.

Brechbuhl HM, Finlay-Schultz J, Yamamoto TM, Gillen AE, Cittelly DM, Tan AC, Sams SB, Pillai MM, Elias AD, Robinson WA, Sartorius CA, Kabos P.

Clin Cancer Res. 2017 Apr 1;23(7):1710-1721. doi: 10.1158/1078-0432.CCR-15-2851. Epub 2016 Oct 4.


Improvements to the HITS-CLIP protocol eliminate widespread mispriming artifacts.

Gillen AE, Yamamoto TM, Kline E, Hesselberth JR, Kabos P.

BMC Genomics. 2016 May 5;17:338. doi: 10.1186/s12864-016-2675-5.


21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.

Jasem J, Amini A, Rabinovitch R, Borges VF, Elias A, Fisher CM, Kabos P.

J Clin Oncol. 2016 Jun 10;34(17):1995-2002. doi: 10.1200/JCO.2015.65.0887. Epub 2016 Mar 21.


The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p.

Towers CG, Guarnieri AL, Micalizzi DS, Harrell JC, Gillen AE, Kim J, Wang CA, Oliphant MUJ, Drasin DJ, Guney MA, Kabos P, Sartorius CA, Tan AC, Perou CM, Espinosa JM, Ford HL.

Nat Commun. 2015 Dec 21;6:10077. doi: 10.1038/ncomms10077.


Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.

Sartorius CA, Hanna CT, Gril B, Cruz H, Serkova NJ, Huber KM, Kabos P, Schedin TB, Borges VF, Steeg PS, Cittelly DM.

Oncogene. 2016 Jun 2;35(22):2881-92. doi: 10.1038/onc.2015.353. Epub 2015 Sep 28.


Multiple Hepatic Lesions in a Patient With a History of DCIS.

Jasem J, Altoos B, Fisher CM, Elias AD, Kounalakis N, Borges VF, Kabos P.

Oncology (Williston Park). 2015 Sep;29(9):669-70, 678-9. No abstract available.


p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer.

Tentler JJ, Ionkina AA, Tan AC, Newton TP, Pitts TM, Glogowska MJ, Kabos P, Sartorius CA, Sullivan KD, Espinosa JM, Eckhardt SG, Diamond JR.

Mol Cancer Ther. 2015 May;14(5):1117-29. doi: 10.1158/1535-7163.MCT-14-0538-T. Epub 2015 Mar 10.


Microwave near-field imaging of two-dimensional semiconductors.

Berweger S, Weber JC, John J, Velazquez JM, Pieterick A, Sanford NA, Davydov AV, Brunschwig B, Lewis NS, Wallis TM, Kabos P.

Nano Lett. 2015 Feb 11;15(2):1122-7. doi: 10.1021/nl504960u. Epub 2015 Jan 30.


Adaptive and robust statistical methods for processing near-field scanning microwave microscopy images.

Coakley KJ, Imtiaz A, Wallis TM, Weber JC, Berweger S, Kabos P.

Ultramicroscopy. 2015 Mar;150:1-9. doi: 10.1016/j.ultramic.2014.11.014. Epub 2014 Nov 23.


GaN nanowire coated with atomic layer deposition of tungsten: a probe for near-field scanning microwave microscopy.

Weber JC, Blanchard PT, Sanders AW, Gertsch JC, George SM, Berweger S, Imtiaz A, Coakley KJ, Wallis TM, Bertness KA, Kabos P, Sanford NA, Bright VM.

Nanotechnology. 2014 Oct 17;25(41):415502. Epub 2014 Sep 26.


Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.

Finlay-Schultz J, Cittelly DM, Hendricks P, Patel P, Kabos P, Jacobsen BM, Richer JK, Sartorius CA.

Oncogene. 2015 Jul;34(28):3676-87. doi: 10.1038/onc.2014.298. Epub 2014 Sep 22.


HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer.

Pillai MM, Gillen AE, Yamamoto TM, Kline E, Brown J, Flory K, Hesselberth JR, Kabos P.

Breast Cancer Res Treat. 2014 Jul;146(1):85-97. doi: 10.1007/s10549-014-3004-9. Epub 2014 Jun 7.


Live multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery.

Reid BG, Jerjian T, Patel P, Zhou Q, Yoo BH, Kabos P, Sartorius CA, Labarbera DV.

Curr Chem Genom Transl Med. 2014 Feb 7;8(Suppl 1):27-35. doi: 10.2174/2213988501408010027. eCollection 2014.


Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.

Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P.

Neuro Oncol. 2014 Jul;16(7):1006-9.


Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells.

Balakrishnan I, Yang X, Brown J, Ramakrishnan A, Torok-Storb B, Kabos P, Hesselberth JR, Pillai MM.

Stem Cells. 2014 Mar;32(3):662-73. doi: 10.1002/stem.1531.


Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.

Axlund SD, Yoo BH, Rosen RB, Schaack J, Kabos P, Labarbera DV, Sartorius CA.

Horm Cancer. 2013 Feb;4(1):36-49. doi: 10.1007/s12672-012-0127-5. Epub 2012 Nov 27.


A near-field scanning microwave microscope for characterization of inhomogeneous photovoltaics.

Weber JC, Schlager JB, Sanford NA, Imtiaz A, Wallis TM, Mansfield LM, Coakley KJ, Bertness KA, Kabos P, Bright VM.

Rev Sci Instrum. 2012 Aug;83(8):083702. doi: 10.1063/1.4740513.


Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Kabos P, Finlay-Schultz J, Li C, Kline E, Finlayson C, Wisell J, Manuel CA, Edgerton SM, Harrell JC, Elias A, Sartorius CA.

Breast Cancer Res Treat. 2012 Sep;135(2):415-32. doi: 10.1007/s10549-012-2164-8. Epub 2012 Jul 24.


Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.

Iwanaga R, Wang CA, Micalizzi DS, Harrell JC, Jedlicka P, Sartorius CA, Kabos P, Farabaugh SM, Bradford AP, Ford HL.

Breast Cancer Res. 2012 Jul 5;14(4):R100. doi: 10.1186/bcr3219.


A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.

Yoo BH, Axlund SD, Kabos P, Reid BG, Schaack J, Sartorius CA, LaBarbera DV.

J Biomol Screen. 2012 Oct;17(9):1211-20. Epub 2012 Jun 29.


Calibrated nanoscale capacitance measurements using a scanning microwave microscope.

Huber HP, Moertelmaier M, Wallis TM, Chiang CJ, Hochleitner M, Imtiaz A, Oh YJ, Schilcher K, Dieudonne M, Smoliner J, Hinterdorfer P, Rosner SJ, Tanbakuchi H, Kabos P, Kienberger F.

Rev Sci Instrum. 2010 Nov;81(11):113701. doi: 10.1063/1.3491926.


Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.

Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA.

Breast Cancer Res Treat. 2011 Jul;128(1):45-55. doi: 10.1007/s10549-010-1078-6. Epub 2010 Jul 28.


Fulvestrant: a unique antiendocrine agent for estrogen-sensitive breast cancer.

Kabos P, Borges VF.

Expert Opin Pharmacother. 2010 Apr;11(5):807-16. doi: 10.1517/14656561003641982. Review.


Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.

Diamond JR, Finlayson CA, Thienelt C, Kabos P, Hardesty L, Barbour L, Klein CE, Rabinovitch R, Elias A, Borges VF.

Oncology (Williston Park). 2009 Aug;23(9):784-91.


Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts.

Horwitz KB, Dye WW, Harrell JC, Kabos P, Sartorius CA.

Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5774-9. doi: 10.1073/pnas.0706216105. Epub 2008 Apr 7.


Broadband electrical characterization of multiwalled carbon nanotubes and contacts.

Rice P, Wallis TM, Russek SE, Kabos P.

Nano Lett. 2007 Apr;7(4):1086-90. Epub 2007 Mar 22.


Neural progenitors populate the cerebrospinal fluid of preterm patients with hydrocephalus.

Krueger RC Jr, Wu H, Zandian M, Danielpour M, Kabos P, Yu JS, Sun YE.

J Pediatr. 2006 Mar;148(3):337-340.


Supplemental Content

Support Center